Zhang W - Search Results

1

LDL-C rebound after long-term evolocumab treatment and intravascular imaging evidence in a familial hypercholesterolemia patient with early-onset myocardial infarction.

Li Z, Zhang S, Yin Z, Zhang W, Sui Y, Li J, Dou K, Qian J, Wu N. Li Z, et al. Among authors: zhang s, zhang w. Chronic Dis Transl Med. 2023 Oct 5;10(1):69-74. doi: 10.1002/cdt3.97. eCollection 2024 Mar. Chronic Dis Transl Med. 2023. PMID: 38450306 Free PMC article. No abstract available.

2

[Early clinical outcomes of percutaneous balloon aortic valvuloplasty in treating high-risk patients with severe aortic stenosis].

Pei H, Wu Y, Yang Y, Teng S, Zhang H, Zhang L, Niu H, Zhang W, Niu G, Qian J, Qiao S, Xu B, Gao R. Pei H, et al. Among authors: zhang l, zhang w, zhang h. Zhonghua Xin Xue Guan Bing Za Zhi. 2015 Jan;43(1):34-8. Zhonghua Xin Xue Guan Bing Za Zhi. 2015. PMID: 25876720 Chinese.

3

[Correlation analysis between 18F-FDG uptake features and the prognosis in patients with pathologic stage Ⅰ lung adenocarcinoma].

Liu Y, Wu N, Bi GC, Zhang DS, Zheng R, Liang Y, Zhang WJ, Li XM, Fang Y. Liu Y, et al. Among authors: zhang ds, zhang wj. Zhonghua Zhong Liu Za Zhi. 2016 Apr;38(4):263-9. doi: 10.3760/cma.j.issn.0253-3766.2016.04.005. Zhonghua Zhong Liu Za Zhi. 2016. PMID: 27087372 Chinese.

4

Three-year outcome of everolimus-eluting bioresorbable vascular scaffold versus everolimus-eluting metallic stents: a comprehensive updated meta-analysis of randomized controlled trials.

Zhang H, Zhao J, Xu Y, Zhang W, Sui Y, Liu Q, Wang Y, Liu Z, Gao R, Wu Y. Zhang H, et al. Among authors: zhang w. Expert Rev Med Devices. 2019 May;16(5):421-427. doi: 10.1080/17434440.2019.1610389. Epub 2019 Apr 28. Expert Rev Med Devices. 2019. PMID: 31008654

5

China Tongxinluo Study for myocardial protection in patients with Acute Myocardial Infarction (CTS-AMI): Rationale and design of a randomized, double-blind, placebo-controlled, multicenter clinical trial.

Xu Y, Li X, Zhang H, Wu Y, Zhang J, Li J, Dou K, Yan H, You S, Yang Y, Liang Y, Xu L, Gao X, Liu C, Dong Q, Zhang W, Song G, Zhang T, Jiang L, Chen G, Tang R, Jin C, Yang J, Yao C, Xian Y, Peterson ED, Gao R, Yang Y. Xu Y, et al. Among authors: zhang w, zhang t, zhang j, zhang h. Am Heart J. 2020 Sep;227:47-55. doi: 10.1016/j.ahj.2020.06.011. Epub 2020 Jun 20. Am Heart J. 2020. PMID: 32679281 Free PMC article.

6

The association of procedural variables and lipid parameters with coronary rotational atherectomy outcomes.

Zhang S, Zhang WJ, Shi HW, Li ZF, Sui YG, Qian J, Wu NQ. Zhang S, et al. Rev Cardiovasc Med. 2021 Dec 22;22(4):1649-1656. doi: 10.31083/j.rcm2204172. Rev Cardiovasc Med. 2021. PMID: 34957807 Free article.

7

Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions.

Zhang S, Li ZF, Shi HW, Zhang WJ, Sui YG, Li JJ, Dou KF, Qian J, Wu NQ. Zhang S, et al. Front Cardiovasc Med. 2022 May 10;9:859567. doi: 10.3389/fcvm.2022.859567. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35620524 Free PMC article.

8

Occult myocardial infarction due to an unusual cause: a case report of periarteritis involving the left coronary artery.

Liu X, Zhao Y, Wu N, Zhang W. Liu X, et al. Among authors: zhang w. Eur Heart J Case Rep. 2022 Apr 26;6(5):ytac182. doi: 10.1093/ehjcr/ytac182. eCollection 2022 May. Eur Heart J Case Rep. 2022. PMID: 35664897 Free PMC article.

9

The Prognostic Value of Cardiac Troponin I in Patients with or without Three-Vessel Disease Undergoing Complete Percutaneous Coronary Intervention.

Li ZF, Zhang S, Shi HW, Zhang WJ, Sui YG, Li JJ, Dou KF, Qian J, Wu NQ. Li ZF, et al. J Clin Med. 2022 Jul 4;11(13):3896. doi: 10.3390/jcm11133896. J Clin Med. 2022. PMID: 35807181 Free PMC article.

10

Effects of intensive lipid lowering compared with moderate-intensity lipid lowering on coronary atherosclerotic plaque phenotype and major adverse cardiovascular events in adults with low to intermediate 10-year ASCVD risk (ILLUMINATION study): protocol for a multicentre, open-label, blinded-endpoint, randomised controlled trial.

Zheng J, Hou Z, Yuan J, Zhao X, Wang Y, Li J, Zhang W, Dou K, Lu B. Zheng J, et al. Among authors: zhang w. BMJ Open. 2023 Jun 5;13(6):e070832. doi: 10.1136/bmjopen-2022-070832. BMJ Open. 2023. PMID: 37277217 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82,667 results

Search Page